Comparison of ALK status between primary and corresponding lymph node metastatic tumors in lung cancer patients

BACKGROUND: The anaplastic lymphoma kinase (ALK) protein has recently become a promising target in the treatment of non-small cell lung carcinomas(NSCLC) patients with ALK translocation because of the high response rates obtained with an ALK inhibitor. ALK translocations are present in approximately...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qiqi, Ma, Honghai, Wang, Bo, Yao, Yake, Zhou, Jianya, Zhou, Jianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752485/
https://www.ncbi.nlm.nih.gov/pubmed/29312572
http://dx.doi.org/10.18632/oncotarget.22294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752485/
https://www.ncbi.nlm.nih.gov/pubmed/29312572
http://dx.doi.org/10.18632/oncotarget.22294

Ejemplares similares